FDA, ASCO propose principles for proper dosing in cancer drug development

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)